Back
MoonLake Immunotherapeutics Stock Predictions
Sponsored
MLTX
Sponsored
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Buy
69
MLTX
MoonLake Immunotherapeutics
Last Price:
51.89
Seasonality Move:
15.96%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.MoonLake Immunotherapeutics Stock Forecast
- Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 119.2% based on the past 4 years of stock performance.
- MoonLake Immunotherapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is MoonLake Immunotherapeutics Stock Undervalued?
The current MoonLake Immunotherapeutics [MLTX] share price is $53.89. The Score for MLTX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal. - MLTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will MoonLake Immunotherapeutics Stock Go Up Next Year?
- Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 119.2% based on the past 4 years of stock performance.
MoonLake Immunotherapeutics Stock Rating
Buy
69
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics overpriced?
- MoonLake Immunotherapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
MoonLake Immunotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moonlaketx.com
52-Week Data
52-Week High:
64.98
52-Week Low:
35.53
Prediction Charts
Market Cap:
3.39B
Price in USD:
53.89
Volume:
267.06K
Beta:
1.29
Technical Analysis
SMA50:
49.47
SMA100:
47.07
SMA200:
47.19
52-Wk Change:
43.13%
Stock Predictions
-
Is MoonLake Immunotherapeutics stock public?
Yes, MoonLake Immunotherapeutics is a publicly traded company. -
What is the MoonLake Immunotherapeutics stock quote today?
The MoonLake Immunotherapeutics stock price is 53.89 USD today. -
How to buy MoonLake Immunotherapeutics stock online?
You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-23 | 48.00 | 46.59 | 48.00 | 46.25 |
Oct-24 | 45.55 | 46.20 | 47.37 | 45.55 |
Oct-25 | 46.58 | 46.70 | 47.22 | 46.07 |
Oct-28 | 47.21 | 48.09 | 48.09 | 46.77 |
Oct-29 | 48.20 | 48.25 | 48.47 | 47.52 |
Oct-30 | 48.02 | 47.00 | 48.17 | 46.28 |
Oct-31 | 47.02 | 46.38 | 47.03 | 45.24 |
Nov-1 | 46.99 | 46.76 | 47.23 | 46.04 |
Nov-4 | 46.37 | 46.40 | 47.46 | 45.27 |
Nov-5 | 47.22 | 47.63 | 48.20 | 45.91 |
Nov-6 | 48.07 | 51.48 | 51.67 | 48.07 |
Nov-7 | 51.98 | 50.67 | 52.34 | 49.60 |
Nov-8 | 50.46 | 51.70 | 52.00 | 50.02 |
Nov-11 | 52.00 | 53.89 | 54.26 | 51.42 |
MoonLake Immunotherapeutics Earnings
MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
MoonLake Immunotherapeutics Forecast Revenue Growth
MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.87 per share, and a decrease next year of $0.69 per share.
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.